Thomas John Dietz's Net Worth
Thomas John Dietz's net worth is estimated to be at least $382,603.30 as of 11/23/2024. CoreStreet's estimation of Thomas John Dietz's net worth is based on their sale of stock and current holding of stock.
Thomas John Dietz is Director at Eiger Biopharmaceuticals Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 50,000 units of EIGR stock on 01/23/2023. Their biggest sale was on 12/21/2018 when they sold 9,330 units of Paratek Pharmaceuticals Inc stock for $46,743.30. They typically trade 1 times per year.
Total value of insider buys:
- $309,535.00
Total value of insider sells:
- $73,068.30
Most recent insider trade:
- Jan. 23, 2023
Thomas John Dietz's Insider Trading History
| Eiger Biopharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 23, 2023 | Director | 50,000 | $1.43 | Buy | $71,500.00 |
Dec. 22, 2022 | Director | 22,500 | $1.17 | Sell | $26,325.00 |
April 9, 2021 | Director | 2,500 | $8.49 | Buy | $21,225.00 |
Jan. 10, 2020 | Director | 4,000 | $13.84 | Buy | $55,360.00 |
April 22, 2019 | Director | 5,000 | $11.05 | Buy | $55,250.00 |
Dec. 20, 2018 | Director | 5,000 | $9.98 | Buy | $49,900.00 |
Dec. 6, 2018 | Director | 5,000 | $11.26 | Buy | $56,300.00 |
| Paratek Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 21, 2018 | Director | 9,330 | $5.01 | Sell | $46,743.30 |